TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | -1 | -3 | -3 | -10 | -26 | -44 | -14 |
| S | %wins | 33 | 67 | 67 | 100 | 100 | 100 | 78 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/24/08 14:48 | 12/22/08 | IDRA | Idera Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Agrawal Sudhir | MA | DO | CEO,P,CS | S.m | -66 | 7.64 | 1 | -9 | -6 | 133 | D | 30 | -34 | -49 | -46 | -9 | 10 | -11 | -14 | 1 | 3 | -6 | -6 | -12 | -30 |
12/19/08 17:20 | 12/17/08 | IDRA | Idera Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Agrawal Sudhir | MA | DO | CEO,P,CS | S.dm | -257 | 8.56 | 1 | -30 | -18 | 141 | D | 94 | -23 | -42 | -40 | 3 | 23 | 3 | 2 | -8 | -7 | -5 | -13 | -25 | -41 |
7/9/08 18:05 | 7/7/08 | IDRA | Idera Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Agrawal Sudhir | MA | DO | CEO,CSO | S.dm | -469 | 13.17 | 3 | -36 | -22 | 129 | D | 296 | 124 | 16 | 14 | -1 | -1 | 2 | 8 | 4 | -4 | 3 | -11 | -40 | -62 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |